SAN DIEGO, May 29, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced the final agenda for the 2013 Process Management & Compliance (PMC) Suite User Conference which will be held June 4-5 at the Princeton Marriott at Forrestal in Princeton, New Jersey. Designed for users of Accelrys Process Management and Compliance Suite products including: Accelrys Electronic Lab Notebook (ELN), Accelrys Laboratory Information Management System (LIMS), Accelrys Lab Execution System (LES), Accelrys Electronic Batch Records (EBR) and Accelrys Discoverant, this two-day conference will feature best practices, product demonstrations, expert user presentations, keynote address and networking events with Accelrys executives, partners and product experts.
"The Accelrys Process Management and Compliance Suite is delivering transformational change in development and compliant operations by connecting lab-to-plant workflows and information across the innovation and commercialization life cycle," said Ken Rapp, senior vice president & managing director, analytical, development, quality and manufacturing solutions group. "Components of the suite are used by 9 out of 10 of the top pharmaceutical companies. User group meetings offer an excellent opportunity for our customers to share their first-hand experiences with the Suite and the many ways it's being implemented."
Representatives from Bristol-Meyers Squibb, IBM, Colgate, Eli Lilly, Johnson & Johnson, Pfizer and more will be presenting at the meeting. The conference is organized into three separate tracks – Product Development, QA/QC and Manufacturing – allowing attendees to focus on the information best suited for them, their company and their needs.Key presentations at the meeting include:
- Transforming the Scientific and Business Dynamics of New Drug Development and Commercialization – How to Harness All Your Data for True Operational Excellence - Ed Francis, IBM
- Not Exactly Process Development: Developing Notebook Templates for Process Chemistry and Reimagining the Role of the Template - Martin Berliner, Pfizer
- Business Case Development for Accelrys LES in a Large Multi-National Pharmaceutical Environment - Colin Taft, Johnson & Johnson
- Generic Pharma Quality Benefits of a LES Platform One Year After Implementation - Deborah Baker and David Redding, Perrigo
- A Recipe-based S88/S95 Approach to Global Harmonization From a Procedure Execution Standpoint - Paul McKenzie, Johnson & Johnson
- Lab Execution in Analytical R&D: from Clinical Materials QC to Production Methods - John Rumney, Bristol-Meyers Squibb
- Evolution of Product Hierarchy Deployment at Biogen Idec to Support the Increase in Drug Substance Manufacturing for BioSimilars - Michael Farrow, Biogen Idec
- Impact of a Global Roll Out of the Accelrys LES on Quality Operations at Lilly - Lukas Gogis, Eli Lilly
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts